3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, AIDS-Related
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Interventions
Doxorubicin
27
Cyclophosphamide
26
Radiotherapy
16
Gemcitabine
16
Filgrastim
11
pembrolizumab
10
pazopanib
10
Radiation
9
Docetaxel
9
Cisplatin
9
fludarabine
7
Trabectedin
7
Ipilimumab
7
Ifosfamide
7
Granulocyte Colony-Stimulating Factor
7
Etoposide
7
Carboplatin
7
Busulfan
7
Bevacizumab
7
olaratumab
6
Temozolomide
6
Peripheral Blood Stem Cell Transplantation
6
Nivolumab
6
Mesna
6
Melphalan
6
selinexor
5
Leucovorin
5
Irinotecan
5
Celecoxib
5
Bortezomib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sarcoma
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled